Display options
Cite
McCann-Crosby B, Mansouri R, Dietrich JE, et al. State of the art review in gonadal dysgenesis: challenges in diagnosis and management. Int J Pediatr Endocrinol. 2014;2014(1):4doi: 10.1186/1687-9856-2014-4.
McCann-Crosby, B., Mansouri, R., Dietrich, J. E., McCullough, L. B., Sutton, V. R., Austin, E. G., Schlomer, B., Roth, D. R., Karaviti, L., Gunn, S., Hicks, M. J., & Macias, C. G. (2014). State of the art review in gonadal dysgenesis: challenges in diagnosis and management. International journal of pediatric endocrinology, 2014(1), 4. https://doi.org/10.1186/1687-9856-2014-4
McCann-Crosby, Bonnie, et al. "State of the art review in gonadal dysgenesis: challenges in diagnosis and management." International journal of pediatric endocrinology vol. 2014,1 (2014): 4. doi: https://doi.org/10.1186/1687-9856-2014-4
McCann-Crosby B, Mansouri R, Dietrich JE, McCullough LB, Sutton VR, Austin EG, Schlomer B, Roth DR, Karaviti L, Gunn S, Hicks MJ, Macias CG. State of the art review in gonadal dysgenesis: challenges in diagnosis and management. Int J Pediatr Endocrinol. 2014;2014(1):4. doi: 10.1186/1687-9856-2014-4. Epub 2014 Apr 14. PMID: 24731683; PMCID: PMC3995514.
Copy Download .nbib Format: NLM
Share it on

Int J Pediatr Endocrinol. 2014;2014(1):4. doi: 10.1186/1687-9856-2014-4. Epub 2014 Apr 14.

State of the art review in gonadal dysgenesis: challenges in diagnosis and management.

International journal of pediatric endocrinology

Bonnie McCann-Crosby, Roshanak Mansouri, Jennifer E Dietrich, Laurence B McCullough, V Reid Sutton, Elise G Austin, Bruce Schlomer, David R Roth, Lefkothea Karaviti, Sheila Gunn, M John Hicks, Charles G Macias

Affiliations

  1. Division of Pediatric Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.
  2. Division of Pediatric and Adolescent Gynecology, Department of Obstetrics and Gynecology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.
  3. Center for Medical Ethics and Health Policy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.
  4. Department of Molecular and Human Genetics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.
  5. Division of Pediatric Urology, Department of Surgery, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.
  6. Department of Pathology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.
  7. Evidence-Based Outcomes Center, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA.

PMID: 24731683 PMCID: PMC3995514 DOI: 10.1186/1687-9856-2014-4

Abstract

Gonadal dysgenesis, a condition in which gonadal development is interrupted leading to gonadal dysfunction, is a unique subset of disorders of sexual development (DSD) that encompasses a wide spectrum of phenotypes ranging from normally virilized males to slightly undervirilized males, ambiguous phenotype, and normal phenotypic females. It presents specific challenges in diagnostic work-up and management. In XY gonadal dysgenesis, the presence of a Y chromosome or Y-chromosome material renders the patient at increased risk for developing gonadal malignancy. No universally accepted guidelines exist for identifying the risk of developing a malignancy or for determining either the timing or necessity of performing a gonadectomy in patients with XY gonadal dysgenesis. Our goal was to evaluate the literature and develop evidence-based medicine guidelines with respect to the diagnostic work-up and management of patients with XY gonadal dysgenesis. We reviewed the published literature and used the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) system when appropriate to grade the evidence and to provide recommendations for the diagnostic work-up, malignancy risk stratification, timing or necessity of gonadectomy, role of gonadal biopsy, and ethical considerations for performing a gonadectomy. Individualized health care is needed for patients with XY gonadal dysgenesis, and the decisions regarding gonadectomy should be tailored to each patient based on the underlying diagnosis and risk of malignancy. Our recommendations, based on the evidence available, add an important component to the diagnostic and management armament of physicians who treat patients with these conditions.

Keywords: Carcinoma in situ; Complete gonadal dysgenesis; Dysgerminoma; Ethics; Gonadal biopsy; Gonadectomy; Gonadoblastoma; Malignancy risk; Partial gonadal dysgenesis; XY gonadal dysgenesis

References

  1. World J Pediatr. 2009 May;5(2):93-102 - PubMed
  2. Cancer. 1979 Feb;43(2):669-78 - PubMed
  3. J Clin Endocrinol Metab. 1983 Aug;57(2):288-93 - PubMed
  4. Hum Pathol. 1982 Aug;13(8):700-16 - PubMed
  5. Am J Hum Genet. 2009 May;84(5):658-63 - PubMed
  6. Sex Dev. 2010 Sep;4(4-5):259-69 - PubMed
  7. Clin Genet. 2005 Jan;67(1):15-25 - PubMed
  8. Am J Hum Genet. 1990 Jun;46(6):1127-40 - PubMed
  9. J Androl. 2003 Mar-Apr;24(2):270-8 - PubMed
  10. J Clin Endocrinol Metab. 2011 Jul;96(7):E1171-80 - PubMed
  11. J Clin Endocrinol Metab. 2000 Sep;85(9):3094-100 - PubMed
  12. BMJ. 2004 Jun 19;328(7454):1490 - PubMed
  13. Curr Opin Pediatr. 2006 Jun;18(3):305-11 - PubMed
  14. J Clin Endocrinol Metab. 2012 Jul;97(7):E1294-306 - PubMed
  15. J Clin Endocrinol Metab. 2000 Sep;85(9):3199-202 - PubMed
  16. Eur J Endocrinol. 2012 Feb;166(2):341-9 - PubMed
  17. Int J Androl. 1987 Feb;10(1):173-80 - PubMed
  18. BJU Int. 2012 Dec;110(11 Pt C):E958-65 - PubMed
  19. J Clin Endocrinol Metab. 2006 Jun;91(6):2404-13 - PubMed
  20. Br Med J (Clin Res Ed). 1986 Nov 29;293(6559):1398-401 - PubMed
  21. J Pediatr Adolesc Gynecol. 2005 Dec;18(6):399-402 - PubMed
  22. Clin Endocrinol (Oxf). 1999 Jan;50(1):19-26 - PubMed
  23. Cancer. 1953 May;6(3):455-63 - PubMed
  24. Cancer. 1970 Jun;25(6):1340-56 - PubMed
  25. Am J Obstet Gynecol. 1976 Feb 1;124(3):293-300 - PubMed
  26. Horm Res Paediatr. 2010;74(6):412-8 - PubMed
  27. Urology. 1994 Apr;43(4):537-40 - PubMed
  28. Eur J Endocrinol. 2012 Apr;166(4):687-94 - PubMed
  29. J Clin Endocrinol Metab. 1975 Apr;40(4):670-4 - PubMed
  30. Cancer Genet Cytogenet. 1987 Apr;25(2):191-218 - PubMed
  31. Best Pract Res Clin Obstet Gynaecol. 2010 Apr;24(2):139-48 - PubMed
  32. Endocr Rev. 2006 Aug;27(5):468-84 - PubMed
  33. J Clin Endocrinol Metab. 2005 Sep;90(9):5295-303 - PubMed
  34. Am J Hum Genet. 2010 Dec 10;87(6):898-904 - PubMed
  35. J Pediatr Endocrinol Metab. 2006 Sep;19(9):1113-7 - PubMed
  36. J Pediatr Urol. 2013 Apr;9(2):139-44 - PubMed
  37. Fertil Steril. 2011 Dec;96(6):1431-4 - PubMed
  38. Urology. 1981 Jun;17(6):584-7 - PubMed
  39. World J Urol. 2004 Apr;22(1):2-14 - PubMed
  40. J Clin Endocrinol Metab. 2012 Aug;97(8):E1540-9 - PubMed
  41. Am J Med Genet A. 2005 Jun 1;135(2):150-4 - PubMed
  42. Eur J Pediatr. 2010 Jun;169(6):671-9 - PubMed
  43. N Engl J Med. 2004 Jan 22;350(4):367-78 - PubMed
  44. Int J Androl. 1987 Feb;10(1):19-28 - PubMed
  45. Int J Gynaecol Obstet. 1996 Oct;55(1):1-10 - PubMed
  46. Am J Hum Genet. 1990 Jan;46(1):156-67 - PubMed
  47. Br Med J. 1955 Sep 17;2(4941):709-12 - PubMed
  48. BJOG. 2008 May;115(6):737-41 - PubMed
  49. J Pediatr. 1985 Mar;106(3):431-6 - PubMed
  50. Eur J Endocrinol. 2009 Aug;161(2):237-42 - PubMed
  51. Pediatrics. 2006 Aug;118(2):e488-500 - PubMed

Publication Types